Shows
The Best of POWER BreakfastThe government is considering offering a vaccine to protect infants against RSV.The government is considering offering a vaccine to protect infants against RSV. Tessa Dooms spoke with Prof Shabir Madhi, professor of vaccinology at Wits University. See omnystudio.com/listener for privacy information.
2025-07-2909 min
The National PulseToday marks exactly five years since President Cyril Ramaphosa placed the nation under a strict lockdown in 2020 to mitigate the spread of Covid-19.Today marks exactly five years since President Cyril Ramaphosa placed the nation under a strict lockdown in 2020 to mitigate the spread of Covid-19. Most of us are probably wondering, what if another pandemic like the deadly Covid-19 outbreak hits the country, will be able to handle it and if so, how well? To shed light on this, I am joined on the line by… GUEST: Professor Shabir Madhi, Dean of Wits University’s faculty of health sciences
2025-03-2708 min
The Jet Set BreakfastJSB HEALTH: Is the Flu Vaccine critical to take during the Flu Season?Is the Flu Vaccine critical to take during the Flu Season? GUEST: DANIEL KAPELUS - Geneticist & Vaccinologist at WITS Vaccines and Infectious Diseases Analytics (VIDA) Research Unit Daniel works alongside Prof Shabir Madhi who is internationally renowned for his research on clinical development of vaccines. Daniel is passionate about how vaccinations can save lives, and talks why South Africans need to take flu, and the flu vaccine, seriously. Flu season usually runs between April and August. The respiratory illness is caused by the influenza virus and spreads through droplets i...
2024-05-0406 min
Carte Blanche: The PodcastThe WholeWeek Wrap with Daily Maverick (6 November 2023)Is there a doctor in the house? Certainly not when it comes to bogus doctor, Matthew Lani. Homeless and hopeless: survivors of the Marshalltown Fire are left to fend for themselves. Then, as loadshedding makes its unwelcome return, Eskom delivers even more bad news. And we pay tribute to two inspiring individuals - Professor Shabir Madhi and Nompilo Dlamini. Carte Blanche Website · Chat on X · Chat on Facebook
2023-11-0619 min
The ResearchWorks PodcastEpisode 123 (Associate Professor Asha Bowen)Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in InfantsList of authors.Beate Kampmann, M.D., Ph.D., Shabir A. Madhi, M.B., B.Ch., Ph.D., Iona Munjal, M.D., Eric A.F. Simões, M.D., Barbara A. Pahud, M.D., M.P.H., Conrado Llapur, M.D., Jeffrey Baker, M.D., Gonzalo Pérez Marc, M.D., David Radley, M.S., Emma Shittu, Ph.D., Julia Glanternik, M.D., Hasra Snaggs, M.D., et al., for the MATISSE Study Group*AbstractBACKGROUND
2023-10-1449 min
The Oxford ColloquyThe Pandemic People: Shabir MadhiShabir Madhi Professor of Vaccinology at the University of the Witwatersrand,Johannesburg, South Africa discusses the effect of the global pandemic on Africa and his work on COVID-19 vaccines. In this episode, Andrew Pollard speaks to Professor Shabir Madhi about his life working in medicine in South Africa and his work on the epidemiology of childhood infectious diseases including HIV. Shabir Madhi is Professor of Vaccinology at the University of the Witwatersrand, Johannesburg, South Africa; and co-founder and co-Director of the African Leadership Initiative for Vaccinology Expertise (ALIVE). His research has focused on the epidemiology, and clinical development of lifesaving...
2023-09-0746 min
Coffee Grab PodcastEPISODE 1: The future of blended learning in health professions - Professor Shabir Madhi"We are talking about blended learning on the one hand, we're talking about BLENDED PRACTICE - and that is going to be the future!", asserts Professor Shabir Madhi (Dean: Faculty of Health Sciences, Wits University). He joined our host, Dr Paula Barnard-Ashton (Assistant Dean: Teaching and Learning, Faculty of Health Sciences, Wits University) for a #CoffeeGrab to discuss his vision for blended learning in the Faculty.
In this debut episode, Prof Madhi shares some of his teaching experiences, faculty initiatives and the need to prepare our students for health professions practice in time of exponential knowledge growth. Professor Shabir...
2023-06-0819 minCoffee Grab PodcastSNEAK PEEK - Prof Shabir MadhiWe thought you might like a sneak peek at our first episode - Prof Shabir Madhi, Dean of the Faculty of Health Sciences at Wits University shares his experiences and vision for blended learning in the faculty. Catch the full first episode when we launch on Thursday 8th June! Catch this SNEAK PEEK in-studio video
2023-06-0101 min
Vuka Online Radio PodcastsHealth Care Hour with Colleen Qvist-Prof Shabir Madhi-PodcastNot so long ago a doctor was suspended for speaking out about conditions in his hospital. There was a public outcry and now silence. Since then we have had a hospital ordering skinny jeans instead of needles. We are also being told that immigrants, not poor management are to blame for hospital conditions.
Join Colleen and special guest, Prof. Shabir Madhi the Dean of the Faculty of Health Sciences and Prof of Vaccinology at Wits. Prof Shabir is a breath of fresh air in that he does not tip-toe around these topics.
#healthcare #governance #accountability V...
2022-09-2345 min
Health & LivingDoctor in the House: Malaysia’s Omicron Wave and What We Can Learn From South AfricaThe year 2022 seems set to be dominated by Omicron, which was first identified by scientists in South Africa late last year. With Malaysia in the midst of an Omicron wave, expected to peak at the end of March, we check in with Prof Dr Shabir Madhi, Professor of Vaccinology at the University of the Witwatersrand, Johannesburg, to find out what we can learn from South Africa’s experience, and whether Omicron will pave the way for COVID-19 to become endemic in our population.Image credit: ShutterstockSee omnystudio.com/listener for privacy information.
2022-02-1846 min
WorldViewThe Vaccine Is SAFE And You Should TAKE It - Prof. Shabir MadhiProf. Shabir Madhi is the Dean of the Faculty of Health Sciences, Professor of Vaccinology at Wits, and co-founder and co-director of the African Leadership Initiative for Vaccinology Expertise. He is leading the first two Covid-19 vaccine studies being undertaken in Africa.
---- Guest Links -----
https://twitter.com/shabirmadh?lang=en
https://www.witshealth.co.za/About/Board/Professor-Shabir-Madhi
https://wits-vida.org/team-member/prof-shabir-madhi/
https://scholar.google.co.za/citations?user=ok2EswEAAAAJ&hl=en
WorldView is...
2022-02-1734 min
The Conversation WeeklyThe inside story of discovering omicron: South African scientists on the lessons their experience offers the rest of the worldWhat is it like to discover a new COVID-19 variant? We hear the inside story from Jinal Bhiman at South Africa's National Institute for Communicable Diseases, one of the scientists who first alerted the world to the omicron variant. And Shabir A Madhi, professor of vaccinology at the University of Witwatersrand, explains what lessons South Africa's experience can offer the rest of the world about future coronavirus variants. We’re joined by Ozayr Patel, digital editor for The Conversation based in Johannesburg for this story.And new research finds a person’s emotional reaction to music has...
2022-02-0350 min
How I make my moneyOther People’s MoneyGuest: Prof Shabir Madhi | Professor in the Respiratory and Meningeal Pathogens Research Unit at University of the Witwatersrand See omnystudio.com/listener for privacy information.
2022-01-3119 min
The Conversation WeeklyPlanet pharma: what the industry got out of COVIDAfter nearly two years of COVID, how is the pharmaceutical industry faring? In this episode, we explore where drug companies were before the arrival of COVID and how they performed financially during the pandemic. And we hear about the ongoing tensions between profits and equitable access to vaccines.Featuring, Ray Moynihan, assistant professor at the Institute for Evidence-Based Healthcare at Bond University in Australia; Jérôme Caby, professor of corporate finance at Sorbonne Business School in Paris, France; Ana Santos Rutschman, assistant professor of law at Saint Louis University in the US; and Nicole Hassoun, pr...
2021-12-0241 min
The Vax Files16. Future Pipeline and Global OutlookNearly two years after Covid-19 was first detected in Wuhan, the world is still very much in a pandemic. The toughest phase may behind us, but we are still faced with the possibility of new variants of concern, waning immunity and vaccine evasion. As first-generation vaccines start to show their weaknesses, next-generation vaccines are becoming more and more important. While hundreds of vaccines are in the pipeline, there are a few frontrunners and other interesting candidates that might be meaningful additions to our Covid vaccine armamentarium. Experts discuss the current status of a number of protein-based vaccines including candidates...
2021-12-0136 min
Podcasts from the EdgeOur Hiding To NothingPeter Bruce talks exclusively to Wits vaccinologist and Dean of medicine Prof Shabir Madhi about our response to the Omicron Covid variant. And there is good news and bad (beyond that fact that Japan has entirely closed its borders, including to the economies that have shut SA out). First, early outbreaks with the variant appear to be relatively mild, at least among vaccinated people. Madhi reckons it could take two to three weeks to see what kinds of pressure hospitals come under. The bad news is that we don’t know enough yet. Madhi warns people who have had ju...
2021-11-2929 minThe Vax Files15. Virus Evolution and Vaccine PressureAs the world tries to take a hold over the delta variant, we're all watching and waiting to see if the virus is going to evolve into something new. There are fears that natural selection could potentially yield a new variant that will completely escape all of our current vaccines. While these scenarios are hypothetical, experts discuss the need to be vigilant and prepared without unnecessary panic. Experts unpack the virus' evolution so far into delta and how that has impacted our goals for herd immunity. They talk about the possibilty for delta to change into a variant more transmissible...
2021-11-2432 min
Pasha - from The Conversation AfricaPasha 132: COVID South Africa: Top scientist on vaccine rollout lessons, and next steps
ShutterstockSouth Africa is several months into its COVID vaccination roll-out – a complex process with wide repercussions. It has recently extended the roll-out to adolescents between the ages of 12 and 17 years. But is this the best use of the available supply of vaccine doses?
Our guest in this episode of Pasha is Shabir Madhi, dean of the faculty of health sciences and professor of vaccinology at the University of the Witwatersrand. He is also director of the South African Medical Research Council’s vaccines and infectious diseases analytics research unit. Professor Madhi believes that the country would be b...
2021-11-0525 min
The Covid ReportAffects of covid-19 vaccine on immunocompromised patientsIn this episode of the Covid Report, we are looking at how the covid-19 pandemic has affected those who are immunocompromised and how getting a vaccine would impact their lives.
To further discuss this, we are joined by Shabir Madhi, Professor of Vaccinology at Wits university, who discusses the affects that immunocompromised individuals might face, given that their immune system is weaker than that of others.
2021-09-1417 min
Utano Podcast | Let's Talk about Health in AfricaLenias Hwenda | Let's Talk about Health in Africa | Government buy-in is key to preventing the implosion of Africa´s vaccine manufacturing businesses31 August 2021 | Governments, private sector and investors are all coming together to rally around the need to establish vaccine manufacturing on the African continent. The success of these efforts whenever depends on securing the market for vaccine manufacturing businesses. Professor Shabir Madhi, the Director of the Rubic Consortium which entered into a technology transfer agreement with Dyadic International tells us more about their plans to make a cost-effective vaccine at a fraction of the cost and what governments must do to secure the industry.
2021-08-3151 minPasha - from The Conversation AfricaPasha 118: Herd immunity isn’t achievable. We need to learn to live with COVID-19shutterstock In the first year of the COVID-19 pandemic the phrase “herd immunity” was bandied about a lot by heads of state as well as health officials. This ideal end state was described as the moment when the virus had been beaten, and everyone could return to a normal life.
But a great deal has changed in the intervening months. Firstly, the virus has mutated in ways that make it spread more quickly, and in ways that make it potentially more resistant.
In addition, the unequal distribution of vaccines, combined with slow rollouts in a grea...
2021-08-0217 min
Life HappensWits Professor Argues That South Africa’s Latest Covid-19 Lockdown Puts Spotlight Back on Vaccination FailuresGuest: Shabir Madhi - Professor of Vaccinology and Director of the SAMRC Vaccines and Infectious Diseases Analytical Research Unit, University of the Witwatersrand
2021-07-0213 minPasha - from The Conversation AfricaPasha 113: COVID-19, the Delta variant and South Africa’s vaccination problemsGettyImages The Delta variant of SARS-COV-2 – the virus that causes COVID-19 – is spreading across South Africa, sparking a strong resurgence of infections. The president has placed the country under stricter regulations in an attempt to curb the spread of the virus. Gauteng province, the country’s economic hub, where 25% of the population live, is the epicentre. It’s likely many more people will be hospitalised in the coming weeks and some will die. Severe disease usually lags behind infections in the community by about two to three weeks.
Based on what happened in India, the number of cases is...
2021-07-0110 min
The Breakfast XpressVACCINE UPDATE WITH PROF SHABIR MADHI#COVID19 #CHOOSELIFESouth Africa has been criticised for its slow vaccine rollout with just over a million people having been vaccinated so far. Should government be recalibrating its expectations? When can we expect to achieve herd-immunity at this rate? We engage Professor of Vaccinology Shabir Madhi...
2021-06-0715 min
Oncology Times - OncTimes TalkOncTimes Talk Research Review May 2021What’s in the OncTimesTalk, May 2021 Edition?
New clinical findings on:
Nivolumab in gastro-esophageal cancer, CDK4/6 inhibition for breast cancer, COVID-19 vaccination limitations, sitagliptin/graft-versus-host disease, breast cancer individualization, neo-adjuvant chemotherapy for rectal cancer.
Featuring:
Ronan Kelly (Austin TX), Erica Mayer (Boston MA), Sibylle Loibl (Frankfurt, Germany), Shabir Madhi (Johannesburg South Africa) and Thierry Conroy (Nancy, France).
Interviews in this edition:
Ronan J Kelly MD MBA, Baylor University Medical Center, Dallas
Adjuvant Nivolumab “Practice Changing” in Resected Gastroesophageal Cancer
Ronan Kelly tells OncTimesTalk about a big reduction in the ri...
2021-05-1339 min
African DialogueSA confirms COVID-19 variants identified in India, BritainSouth Africa’s Department of Health has confirmed variants of the COVID-19 virus first identified in India and Britain, have been detected in South Africa. Two cases of the B.1.617.2 variant - dominant in India - have been reported in Gauteng and another two reported in KwaZulu-Natal. A total of 11 cases of another variant - B.1.1.7, first detected in Britain - have been reported in the country - eight in the Western Cape, one in KwaZulu-Natal and two in Gauteng. Wits University vaccinology expert - Professor Shabir Madhi - says new variants and mutations are inevitable. However, he says the ch...
2021-05-1158 min
African DialogueSA confirms COVID-19 variants identified in India, BritainSouth Africa’s Department of Health has confirmed variants of the COVID-19 virus first identified in India and Britain, have been detected in South Africa. Two cases of the B.1.617.2 variant - dominant in India - have been reported in Gauteng and another two reported in KwaZulu-Natal. A total of 11 cases of another variant - B.1.1.7, first detected in Britain - have been reported in the country - eight in the Western Cape, one in KwaZulu-Natal and two in Gauteng. Wits University vaccinology expert - Professor Shabir Madhi - says new variants and mutations are inevitable. However, he says the ch...
2021-05-1158 min
The Breakfast XpressVACCINE UPDATE WITH PROF SHABIR MADHI#COVID19 #CHOOSELIFEEven though 43 million doses of vaccines have been secured for SA, it’s trickling in slowly. So, when can we expect to inoculate the masses and attain herd immunity? We chat to Professor Shabir Madhi to get some answers
2021-03-1612 min
RSG Nuus & AktualiteitMonitor 2 Maart 2021 - Deel 2Ons praat met twee misdaad- en polisiekenners oor bendegeweld in Kaapstad, wat aan die toeneem is. Boere wêreldwyd gebruik toenemend tegnologie om hulle kuddes te bestuur. Professor Shabir Madhi van Wits sê 'n derde vlaag van Covid-19-infeksies word in Mei of Junie verwag.
2021-03-0243 min
Khwezi Science ReportProf Madhi on whether you can get reinfected once you've had Covid-19?Vaccines are the talk of the town, but what about the natural immunity (or lack thereof) enjoyed by those who have suffered through Covid-19 disease? And what about those who were infected but asymptomatic? Do they have any antibodies to speak of? And what about immunity against the new variant if you got sick in the first wave? And is an antibody test even worth getting? In this podcast, Sunday Times senior science reporter Tanya Farber digs into some of these questions with the esteemed Professor Shabir Madhi, a global leader in infectious diseases and a vaccinologist at Wits University...
2021-02-1117 minPasha - from The Conversation AfricaPasha 95: Key questions answered on the results of the Novavax vaccine trialsshutterstock Novavax vaccine trials run in South Africa and the UK indicate that its efficacy in the UK was 89% at least 7 days after individuals had received two doses of vaccine. In South Africa, the vaccine efficacy was 60% in people living without HIV.
The trial is being viewed as highly significant because it is the first vaccine to be tested on a particular COVID-19 variant first identified in South Africa.
In today’s episode of Pasha Shabir Madhi, professor of vaccinology and director of the vaccines and infectious diseases analytics research unit at the University of th...
2021-02-0119 min
Newscast - AfricaSouth African Trial Of Novavax Vaccine Seen To Be 60% EffectiveThe principal investigator of the study said late on Thursday said South Africa’s mid-stage trial of U.S.-based biotech company Novavax Inc’s COVID-19 vaccine has shown it to be 60% effective for non-HIV individuals.<br />Shabir Madhi, a professor of vaccinology at the University of the Witwatersrand leading the clinical study for Novavax COVID-19 vaccine in South Africa, said the results were good and showed the vaccine is highly effective towards immunization against the coronavirus.<br />He said the results are far superior than any other vaccine against the new variant.
2021-01-2908 minPasha - from The Conversation AfricaPasha 91: Blunders that left South Africa trailing in the vaccine stakesshutterstock The South African government has announced plans to vaccinate about two-thirds of its population against COVID-19 by the end of the year. The aim is to do this in three phases, starting with healthcare workers in phase one, the elderly and those with co-morbidities in phase two and the rest of the population in phase three.
But the plan has been vehemently attacked as lacking in any detail. In addition, the government has been lambasted for failing to acquire vaccines.
Shabir Madhi unpacks what’s gone wrong. The first major error was the South Af...
2021-01-1417 min
Podcasts from the EdgeTough love and real science for RamaphosaTop South African vaccinologist Shabir Mahdi strongly advises against any further strengthening of lockdown regulations in this edition of Podcasts from the Edge with Peter Bruce and ahead of President Cyril Ramaphosa’s address to the nation. Tougher restrictions won’t work, he says, and we have to keep people outdoors and in the wind, We will only know in a few weeks whether or not current vaccines are going to be effective against the new South African variant of the coronavirus, Madhi warns, but there’s clear evidence that antibodies produced in people infected in the first wave last y...
2021-01-1142 min
Inside Covid-19Inside Covid-19: SA variant - what it means for vaccine development, ending pandemic - Prof MadhiThe South African variant of Covid-19 has changed the outlook for the way the coronavirus pandemic is likely to unfold - in South Africa as well as elsewhere. Scientists in South Africa say there is a "reasonable concern" that the new variant of Covid-19 sweeping across the country might prove to be more resistant to current vaccines being rolled out in the UK and elsewhere, and warn that it makes the need for a global roll-out of vaccines "even more critical”. In this episode of Inside Covid-19, we have a special interview with one of South Africa’s leading scientists in t...
2021-01-0736 min
Inside Covid-19Inside Covid-19: SA variant - what it means for vaccine development, ending pandemic - Prof MadhiThe South African variant of Covid-19 has changed the outlook for the way the coronavirus pandemic is likely to unfold - in South Africa as well as elsewhere. Scientists in South Africa say there is a "reasonable concern" that the new variant of Covid-19 sweeping across the country might prove to be more resistant to current vaccines being rolled out in the UK and elsewhere, and warn that it makes the need for a global roll-out of vaccines "even more critical”. In this episode of Inside Covid-19, we have a special interview with one of South Africa’s leading scientists in t...
2021-01-0736 min
The Breakfast XpressCOVID19 VACCINE Q & A WITH DR RAMLACHAN#COVID19 #CHOOSELIFEAfter unpacking government’s vaccine rollout plan with Vaccinologist Professor Shabir Madhi yesterday, we were inundated with medical questions around the vaccine. So to get some answers for you, we’ve invited Dr Preiti Ramlachan on the show this morning...
2021-01-0713 min
The Breakfast XpressPROF SHABIR MADHI ON COVID19 VACCINES#COVID19 #CHOOSELIFEIs South Africa’s vaccine rollout plan realistic and will we meet the targets set out by government? We ventilate this with Vaccinologist Professor Shabir Madhi.
2021-01-0628 min
AM Live on SAfmCriticism of government's vaccine roll-out planGovernment has been widely criticized for its approach in the race to procure a vaccine. Health Minister Zweli Mkhize says structures have been set up to expedite procurement of the COVID-19 vaccine. More than 40 million South Africans, are targeted to receive the COVID-19 vaccine by the end of the year. He further says so far government has only secured enough dosages to immunise 10% of the population. We spoke to Prof. Shabir Madhi, Professor of Vaccinology at Wits University.
2021-01-0408 min
VOC BreakfastResurgence of Covid-19 in SA due to super spreader events and poor indoor ventilationSecond waves of Covid-19 are hitting countries all over the world, increasing deaths. South Afirca is no different as indoor super spreader events are the main culprit, according to Wits Professor Shabir Mahdi. Health minister Dr Zweli Mkhize has confirmed that a second wave of infections had hit SA.
Joining us online is Prof Shabir Madhi - vaccinologist at Wits University who has been leading clinical trials for Covid-19 vaccines in SA.
2020-12-1007 minInside Covid-19Inside Covid-19: vaccine roll-out in SA, beyond - experts, pharmacy bossesWith billions of dollars a day disappearing as much of the northern hemisphere is shutdown to contain the spread of Covid-19, it is critical for vaccines to be rolled out as soon as possible. In this episode of Inside Covid-19, we focus on vaccine roll out in Africa and elsewhere. Coming up: We hear from Professor Shabir Madhi, vaccines expert at the University of the Witwatersrand, and Chief Executive Officer of AstraZeneca Pascal Soriot who says supply partners are getting ready to produce hundreds of millions of doses of their vaccine. Also in the programme, Nobel Laureate, Michael Kremer, shares...
2020-11-3029 min
Inside Covid-19Inside Covid-19: vaccine roll-out in SA, beyond - experts, pharmacy bossesWith billions of dollars a day disappearing as much of the northern hemisphere is shutdown to contain the spread of Covid-19, it is critical for vaccines to be rolled out as soon as possible. In this episode of Inside Covid-19, we focus on vaccine roll out in Africa and elsewhere. Coming up: We hear from Professor Shabir Madhi, vaccines expert at the University of the Witwatersrand, and Chief Executive Officer of AstraZeneca Pascal Soriot who says supply partners are getting ready to produce hundreds of millions of doses of their vaccine. Also in the programme, Nobel Laureate, Michael Kremer, shares...
2020-11-3029 min
The Breakfast XpressVACCINE UPDATE WITH PROF SHABIR MADHI#COVID19 #ChooseLifeIn the race to find a vaccine, how far behind are we? Is it something we will have to buy, will medical aid cover it or will it be free for everyone? What does the percentage efficacy really mean? We get some answers from one of South Africa’s leading scientists, Prof Shabir Madhi.
2020-11-2313 minAfrican DialogueCovid19 Vaccine UpdateAccording to pharmaceutical companies Pfizer and BioNTech, their new vaccine has exceeded all expectations so far in clinical trials. They said it is more than ninety-percent effective at preventing Covid-19 symptoms. About 44 000 people have enrolled in the clinical trials for this vaccine, which are taking place in several countries, including South Africa. The Pfizer/BioNTech vaccine exploits new technology that has never before been used in vaccines another reason to treat it with caution. It uses mRNA (messenger ribonucleic acid) to tell the body to produce viral proteins which stimulate an immune response in the body. Although effective, there are co...
2020-11-1634 min
African DialogueCovid19 Vaccine UpdateAccording to pharmaceutical companies Pfizer and BioNTech, their new vaccine has exceeded all expectations so far in clinical trials. They said it is more than ninety-percent effective at preventing Covid-19 symptoms. About 44 000 people have enrolled in the clinical trials for this vaccine, which are taking place in several countries, including South Africa. The Pfizer/BioNTech vaccine exploits new technology that has never before been used in vaccines another reason to treat it with caution. It uses mRNA (messenger ribonucleic acid) to tell the body to produce viral proteins which stimulate an immune response in the body. Although effective, there are co...
2020-11-1634 minInside Covid-19Inside Covid-19: Lockdowns are the biggest health policy mistake in living memory - Great Barrington Declaration founderIn this episode of inside Covid-19, we have two special interviews for you - with medical experts of global standing. First up, we speak to Dr Jay Bhattacharya, a professor of medicine at Stanford University. Dr Bhattacharya is one of the driving forces behind the Great Barrington Declaration, which calls for a rethink on lockdowns and an ‘intelligent’ approach to protecting the vulnerable. He has taken a lot of flak from government advisors and others, but is pursuing his commitment to Focused Protection because his conscience won’t allow him to do otherwise. Dr Battacharya’s message resonates with South Africa’s...
2020-11-1149 min
Inside Covid-19Inside Covid-19: Lockdowns are the biggest health policy mistake in living memory - Great Barrington Declaration founderIn this episode of inside Covid-19, we have two special interviews for you - with medical experts of global standing. First up, we speak to Dr Jay Bhattacharya, a professor of medicine at Stanford University. Dr Bhattacharya is one of the driving forces behind the Great Barrington Declaration, which calls for a rethink on lockdowns and an ‘intelligent’ approach to protecting the vulnerable. He has taken a lot of flak from government advisors and others, but is pursuing his commitment to Focused Protection because his conscience won’t allow him to do otherwise. Dr Battacharya’s message resonates with South Africa’s...
2020-11-1149 minPasha - from The Conversation AfricaPasha 84: South Africa and a resurgence of COVID-19shutterstock South Africa will almost certainly experience a resurgence of COVID-19. However, this new round is likely to be lower than the first round of infections in the country. This is because at the peak earlier in the year, restrictions were being eased and an estimated 35%-40% of South Africans had already been infected with the virus. The worry is that this time round the country’s hospitals could come under great pressure if people don’t adhere to non-pharmaceutical interventions – like wearing a mask and physical distancing.
In today’s episode of Pasha we talk to Shabir M...
2020-10-2814 min
Science Allies - Biotechnology, Agriculture, Ecology, Health, and Critical ThinkingCOVID vaccine: What’s at stake for Africa?Prof. Shabir A. Madhi, professor of vaccinology at the University of the Witwatersrand, Johannesburg, South Africa, and Dr. Michael Owusu, a clinical microbiologist and a lecturer at Kwame Nkrumah University of Science and Technology, Ghana, discuss Africa’s critical role in the global efforts to develop a vaccine for COVID-19. Topics include the current status and safety of clinical trials of vaccines; how vaccines are developed and distributed; the policy and regulatory requirements for development, registration, access and use of vaccines; the safety and efficacy of vaccines; the role of public sentiment in accepting or rejecting a COVID vaccine; and p...
2020-09-251h 29The Covid ReportWhat do we know about covid-19 since the first case in RSA?On The Covid Report today we speak to Professor Shabir Madhi about how South Africa has managed the coronavirus pandemic since the first case was reported in March. He also speaks to us about the vaccine trials that South Africa has been involved in. Madhi is a Professor of Vaccinology in the School of Pathology at the University of the Witwatersrand and Director of the world-renowned Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit (VIDA), A National Research Foundation A-rated scientist.
2020-09-1632 min
Inside Covid-19Inside Covid-19: tracing app and your privacy; what's next for vaccine in SA, and the pandemic - Prof Madhi Ep 82In this episode, we talk to a data and privacy law specialist Emma Sadleir on the skepticism surrounding Covid-19 contact tracing apps and Professor Shabir Madhi, one of South Africa’s pre-eminent experts on vaccines. Professor of Vaccinology at the University of the Witwatersrand, he has published more than 350 studies in his field. Professor Madhi speaks to us about the latest developments in Covid-19 vaccine trials, including the news that the AstraZeneca Oxford trial has been temporarily put on hold. And he shares the details of a study that explores the possibility that South Africans may have developed immunity to Co...
2020-09-0932 minInside Covid-19Inside Covid-19: tracing app and your privacy; what's next for vaccine in SA, and the pandemic - Prof Madhi Ep 82In this episode, we talk to a data and privacy law specialist Emma Sadleir on the skepticism surrounding Covid-19 contact tracing apps and Professor Shabir Madhi, one of South Africa’s pre-eminent experts on vaccines. Professor of Vaccinology at the University of the Witwatersrand, he has published more than 350 studies in his field. Professor Madhi speaks to us about the latest developments in Covid-19 vaccine trials, including the news that the AstraZeneca Oxford trial has been temporarily put on hold. And he shares the details of a study that explores the possibility that South Africans may have developed immunity to Co...
2020-09-0932 min
PM Live on SAfmExposure to other serious diseases in the past may have created an immunity to COVID-19 for South Africans - Prof MadhiSAfm — Exposure to other serious diseases in the past may have created an immunity to COVID-19 for many South Africans. That's according to Professor of Vaccinology at the University of the Witwatersrand, Shabir Madhi. He's currently looking into why South Africa's death rate is far lower than was initially predicted. This comes as the number of daily new infections has also dipped sharply.
2020-09-0804 min
SABC Joburg News FeaturesExposure to other illnesses may have created immunity to COVID-19Exposure to other serious diseases in the past may have created an immunity to COVID-19 for many South Africans. That's according to Professor of Vaccinology at the University of the Witwatersrand, Shabir Madhi. He's currently looking into why South Africa's death rate is far lower than was initially predicted. This comes as the number of daily new infections has also dipped sharply. Prabashini Moodley reports...
2020-09-0704 minPasha - from The Conversation AfricaPasha 78: South Africa’s second COVID-19 vaccine trial explainedshutterstock Trials have begun in South Africa for a second COVID-19 vaccine study. The hope is that at least one of the vaccines being trialled will show promise and play a role in eliminating the SARS-CoV-2 coronavirus.
In this episode of Pasha, Shabir Madhi, professor of vaccinology and director of the vaccines and infectious diseases analytics research unit at the University of the Witwatersrand, explains why there are multiple vaccine studies under way, the differences between them, how this second South African trial works and when the results might be known.
Read more:
Pasha 71: COVID-19...
2020-08-2612 min
SABC Joburg News FeaturesAnother Covid-19 vaccine trail has started in South Africa - Novavex led by Wits Prof Shabir MadhiAnother Covid-19 vaccine trail has started in South Africa. The Novavax clinical trial is being led by Wits University professor Shabir Madhi. Studies of the Novavax vaccine conducted on non-human primates showed protection against SARS-Cov-2 infection in the nasal passage and lung disease. Madhi says the trial will help the country generate evidence on how well these vaccines work in an African context. Pearl Magubane reports
2020-08-1802 min
Inside Covid-19Inside Covid-19: Wits gets second global vaccine trial - this time Novavax; Vitality enhancements for over 65s. Ep 73In episode 73 of Inside Covid-19 there's a focus on vaccines – first with Wits professor Shabir Madhi whose unit was selected by US drug company Novavax to run a critical 2b trial of its coronavirus vaccine. Courtesy of a $15m donation from the Gates Foundation, Wits will conduct a 2,900 person trial of the Novavax vaccine; it began a similar trial for the promising Oxford University vaccine seven weeks ago. We’ll also hear from our partners at Bloomberg why the civilized world isn’t banking on Russia’s Sputnik V vaccine which was announced last week. Also tonight, Discovery’s Vitality creates fr...
2020-08-1732 minInside Covid-19Inside Covid-19: Wits gets second global vaccine trial - this time Novavax; Vitality enhancements for over 65s. Ep 73In episode 73 of Inside Covid-19 there's a focus on vaccines – first with Wits professor Shabir Madhi whose unit was selected by US drug company Novavax to run a critical 2b trial of its coronavirus vaccine. Courtesy of a $15m donation from the Gates Foundation, Wits will conduct a 2,900 person trial of the Novavax vaccine; it began a similar trial for the promising Oxford University vaccine seven weeks ago. We’ll also hear from our partners at Bloomberg why the civilized world isn’t banking on Russia’s Sputnik V vaccine which was announced last week. Also tonight, Discovery’s Vitality creates fr...
2020-08-1732 minThe Covid ReportCovid19 infections on the rise, and the latest on the vaccine trials with Prof Shabir MadhiOn the Cover Report we speak to Professor Shabir Madhi, a Professor of Vaccinology in the School of Pathology at the University of the Witwatersrand and Director of the world-renowned Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit (VIDA), A National Research Foundation A-rated scientist.
2020-07-2917 min
African DialogueCOVID-19 vaccine trialsThe World Health Organization (WHO) has welcomed developments in COVID-19 vaccine trials, singling out an Oxford University group while noting that the next move will have to be larger-scale real-world trials. The Lancet medical journal, reporting that Oxford University's coronavirus vaccine is safe and produces a positive immune reaction. The early-stage human trials involved around 1,077 people with the results showing that the participants produced antibodies and white blood cells that can fight the virus. Meanwhile in South Africa over 400 participants have so far been enrolled in South Africa’s COVID-19 vaccine efficacy trial.The first potential vaccines we...
2020-07-2839 minAfrican DialogueCOVID-19 vaccine trialsThe World Health Organization (WHO) has welcomed developments in COVID-19 vaccine trials, singling out an Oxford University group while noting that the next move will have to be larger-scale real-world trials. The Lancet medical journal, reporting that Oxford University's coronavirus vaccine is safe and produces a positive immune reaction. The early-stage human trials involved around 1,077 people with the results showing that the participants produced antibodies and white blood cells that can fight the virus.
Meanwhile in South Africa over 400 participants have so far been enrolled in South Africa’s COVID-19 vaccine efficacy trial.
The first potential vaccines were administered to so...
2020-07-2839 min
The Recovery ProjectThe Race to Find a VaccineUnlike previous pandemics of this century, COVID-19 has touched every corner of the world and is proving deadlier than SARS, H1N1, and MERS. Listen to a recording of The Recovery Project livestream on the principles and progress-to-date in COVID-19 vaccine development in different regions of the world, and what roles education, awareness and health systems play.
We were joined by Dr. Alan Bernstein, president and CEO of CIFAR and founding head of the Global HIV Vaccine Enterprise, and Dr. Shabir Madhi, professor of vaccinology at Witwatersrand University in Johannesburg and co-founder and co-director of the African Leadership Initiative for...
2020-07-2100 minPasha - from The Conversation AfricaPasha 71: COVID-19 vaccine trial in South Africa explainedshutterstock South African researchers, in collaboration with Oxford University’s Jenner Institute, are trialling a vaccine for the COVID-19. Trials of this nature are important because they give robust data about the safety of vaccines. Being part of the trial will also mean that South Africa won’t lag behind should a vaccine prove to work. But how exactly does the trial work? Who receives the vaccine and the placebo? Are South African volunteers being used as “guinea pigs”?
In this episode of Pasha, Shabir Madhi, professor of vaccinology and Director of the MRC Respiratory and Meningeal Pathogen...
2020-07-0809 min
African DialogueProfessor Shabir MadhiThe first clinical trial in South Africa and on the continent for a Covid-19 vaccine was announced today, 23 June 2020. As of today there are 168 thousand confirmed covid 19 cases with just under 3 000 deaths and most importantly 81 000 recoveries. For our one on one lets welcome the man who has the enormous task of leading the team of experts and scientists in the covid 19 vaccine trial Professor Shabir Madhi who is a Professor of Vaccinology at the University of the Witwatersrand. Wits University is collaborating with the University of Oxford and the Oxford Jenner Institute on the South African trial.
2020-07-0322 minAfrican DialogueProfessor Shabir MadhiThe first clinical trial in South Africa and on the continent for a Covid-19 vaccine was announced today, 23 June 2020. As of today there are 168 thousand confirmed covid 19 cases with just under 3 000 deaths and most importantly 81 000 recoveries. For our one on one lets welcome the man who has the enormous task of leading the team of experts and scientists in the covid 19 vaccine trial Professor Shabir Madhi who is a Professor of Vaccinology at the University of the Witwatersrand. Wits University is collaborating with the University of Oxford and the Oxford Jenner Institute on the South African trial.
2020-07-0322 min
The Breakfast XpressINTERVIEW WITH VACCINOLOGIST DR SHABIR MADHI#COVID19 #CHOOSELIFEOne of South Africa’s leading scientists, Prof Shabir Madhi joins us on the show today. He will answer our burning questions about the coronavirus and potential vaccine.
2020-07-0113 minAfrican DialogueSouth Africa Covid-19 Vaccine TrialOxford University rolled out Africa's first human trials for a potential vaccine against the new coronavirus in South Africa on Wednesday, as cases continue to rise. The trial, conducted with local partner the University of the Witwatersrand, will consist of two-thousand volunteers from 18 to 65 years of age, including some HIV positive patients, who will be monitored for 12 months after vaccination to assess how well the vaccine guards against COVID-19. South Africa is the second country outside of the United Kingdom to take part in the Oxford trial after Brazil launched its study on Wednesday. Professor Shabir Madhi is a professor...
2020-06-2537 min
African DialogueSouth Africa Covid-19 Vaccine TrialOxford University rolled out Africa's first human trials for a potential vaccine against the new coronavirus in South Africa on Wednesday, as cases continue to rise. The trial, conducted with local partner the University of the Witwatersrand, will consist of two-thousand volunteers from 18 to 65 years of age, including some HIV positive patients, who will be monitored for 12 months after vaccination to assess how well the vaccine guards against COVID-19. South Africa is the second country outside of the United Kingdom to take part in the Oxford trial after Brazil launched its study on Wednesday. Professor Shabir Madhi is a professor...
2020-06-2537 minThe Covid ReportFirst COVID-19 vaccine trial in South Africa beginThe first clinical trial for for a vaccine against Covid-19 will star this week. This was announce on 23 June 2020, during a virtual press conference hosted by the University of the Witwatersrand, Johannesburg. The South African Ox1Cov-19 Vaccine VIDA-Trial aims to find a vaccine that will prevent infection by SARS-CoV-2, the virus that causes Covid-19.In South Africa, at least 80,000 people have already been diagnosed with Covid-19 and more than 1,674 have died from Covid-19 since March, when the President declared a state of disaster and national lockdown.
SPEAKERS at the announcement included Professor Johnny Mahlangu, Head of the Scho...
2020-06-231h 28
VOW MomentsFirst COVID-19 vaccine trial in South Africa beginVOW FM 88.1 — The first clinical trial for for a vaccine against Covid-19 will star this week. This was announce on 23 June 2020, during a virtual press conference hosted by the University of the Witwatersrand, Johannesburg. The South African Ox1Cov-19 Vaccine VIDA-Trial aims to find a vaccine that will prevent infection by SARS-CoV-2, the virus that causes Covid-19.In South Africa, at least 80,000 people have already been diagnosed with Covid-19 and more than 1,674 have died from Covid-19 since March, when the President declared a state of disaster and national lockdown.
SPEAKERS at the announcement included Professor Johnny Mahlangu, Head of the...
2020-06-231h 28
RSG Nuus & AktualiteitMonitorRSG — Disabled People South Africa in die Noord-Kaap sê die blindes wat hulle verteenwoordig voel dat die Coronavirus Pandemie hulle veral swaar tref.; Die minimum ouderdom waarop 'n kind strafregtelik aangekla kan word is verhoog na 12.; Professor Shabir Madhi van Wits universiteit sê die Oos-Kaap gaan die volgende fokus gebied van die Covid-19 pandemie wees.; en landsburgers in sestien lande wil hê hul regerings moet die omgewing se bewaring n prioriteit maak na die Covid-19 pandemie.
2020-06-0954 min
NightTalk with Gushwell BrooksPost nation address #Covid-19 Level 3 – Medical perspectiveProfessor Shabir Ahmed Madhi, currently serves as the Chair of the National Advisory Group Immunization in South Africa | Director of the Medical Research Council Respiratory and Meningeal Pathogens Research Unit and Research Chair at Department of Science and Technology/National Research Foundation in Vaccine Preventable Diseases at the University of the WitwatersrandSee omnystudio.com/listener for privacy information.
2020-05-2419 min
NightTalk with Gushwell BrooksThe Inside Track: Three months ‘State of Disaster’ Covid-19 SpecialMark Heywood, Maverick Citizen editor, in conversation with Professor Shabir Madhi, Professor of Vaccinology at Wits University on their Daily Maverick Live Webinar to navigate the war on Covid-19 Stage 4.See omnystudio.com/listener for privacy information.
2020-05-1045 min
Wits Impacts For GoodWhy do our babies die? Wits researcher unravels mystery around stillbirthsMeet Shabir Ahmed Madhi – the Wits professor pioneering the vaccine to prevent stillbirths amongst pregnant women in impoverished communities, who are dependent on public health facilities. #ForGood Visit the Wits Impacts For Good feature page: https://www.702.co.za/features/411/the-wits-impacts-for-good-podcast-seriesSee omnystudio.com/listener for privacy information.See omnystudio.com/listener for privacy information.
2020-05-0425 min
PM Live on SAfmPossible end to NHLS strikeSAfm — Management at the National Health Laboratory Services say a strike by its workers could lead to delays for those waiting for test results. Thousands of workers began an indefinite nationwide strike yesterday. Workers and management have agreed on to a 7.3 % salary increase but are still to finalize other issues relating to benefits. The NHLS is the only service provider of laboratory services at public hospitals and clinics. Elvis Presslin spoke to Professor Shabir Madhi National Health Laboratory Services
2017-07-2704 min
Midday LiveNehawu strike at National health laboratories continuesWorkers affiliated to labour union Nehawu are continuing their strike action at the National Health Laboratory Service. The Union says wage negotiations reached a deadlock over a pay increase and other issues. The Laboratory Service provides diagnostic pathology services to government, such as blood tests. Acting CEO at the National Health Laboratories Services in Johannesburg Professor Shabir Madhi says they have put contingency measures in place which have, largely, been working, but adds that there have been some challenges.
2017-07-2704 min
The Forum@8what do South Africans need to know about the deadly Ebola virus?The World Health Organization has called the current Ebola virus outbreak "the most severe, acute health emergency seen in modern times". The epidemic has killed more than four-thousand people, mainly in the West African countries of Liberia, Sierra Leone and Guinea. The number of reported cases stands at more than 8 300. On the Forum@8 this morning we ask; what do South Africans need to know about the deadly Ebola virus…. Our guest Health Minister Aaron Mostsoaledi- Department of Health, Professor Shabir Madhi, Executive Director at the National Institute for Communicable Diseases and Gem Patten is an epidemiologist with Médecins Sans Fro...
2014-10-1442 min